0001415889-24-002567.txt : 20240205
0001415889-24-002567.hdr.sgml : 20240205
20240205164552
ACCESSION NUMBER: 0001415889-24-002567
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Manji Husseini
CENTRAL INDEX KEY: 0002009654
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41944
FILM NUMBER: 24596440
MAIL ADDRESS:
STREET 1: C/O ALTO NEUROSCIENCE, INC.
STREET 2: 369 SOUTH SAN ANTONIO ROAD
CITY: LOST ALTOS
STATE: CA
ZIP: 94022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alto Neuroscience, Inc.
CENTRAL INDEX KEY: 0001999480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 834210124
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 369 SOUTH SAN ANTONIO RD.
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
BUSINESS PHONE: 773-255-5012
MAIL ADDRESS:
STREET 1: 369 SOUTH SAN ANTONIO RD.
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
4
1
form4-02052024_090245.xml
X0508
4
2024-02-01
0001999480
Alto Neuroscience, Inc.
ANRO
0002009654
Manji Husseini
C/O ALTO NEUROSCIENCE, INC.
369 SOUTH SAN ANTONIO ROAD
LOS ALTOS
CA
94022
true
false
false
false
0
Stock Option (right to buy)
16
2024-02-01
4
A
0
30574
0
A
2034-01-31
Common Stock
30574
30574
D
Stock Option (right to buy)
16
2024-02-01
4
A
0
3083
11.884
A
2034-01-31
Common Stock
3083
3083
D
The shares underlying the option shall vest in 36 equal monthly installments commencing on March 1, 2024, subject to the Reporting Person's continuous service through each vesting date.
560 shares underlying the option shall vest on March 31, 2024, and 841 shares underlying the option shall vest on each of June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service through each such vesting date.
This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $36,667.
/s/ Erin R. McQuade, Attorney-in-Fact
2024-02-05